Aimmune Therapeutics Inc Precio/Valor contable
¿Qué es el Precio/Valor contable de Aimmune Therapeutics Inc?
El Precio/Valor contable de Aimmune Therapeutics Inc es 17.87
¿Cuál es la definición de Precio/Valor contable?
El ratio precio-valor contable representa la relación entre el valor de las acciones de una empresa y el valor contable por acción.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Precio/Valor contable de compañías en Sector Health Care en NASDAQ en comparadas con Aimmune Therapeutics Inc
Empresas con precio/valor contable similar a Aimmune Therapeutics Inc
- Blue Sky Uranium tiene Precio/Valor contable de 17.73
- Waters tiene Precio/Valor contable de 17.76
- Patrys tiene Precio/Valor contable de 17.78
- GlaxoSmithkline Pharmaceuticals tiene Precio/Valor contable de 17.79
- Argent Minerals tiene Precio/Valor contable de 17.80
- GPM Metals tiene Precio/Valor contable de 17.87
- Aimmune Therapeutics Inc tiene Precio/Valor contable de 17.87
- IWG Plc tiene Precio/Valor contable de 17.90
- Infrastructure and Alternatives Inc tiene Precio/Valor contable de 17.90
- Sarytogan Graphite tiene Precio/Valor contable de 17.90
- CURE Pharmaceutical tiene Precio/Valor contable de 17.93
- Objective tiene Precio/Valor contable de 17.94
- Prime Securities tiene Precio/Valor contable de 17.98